GENERATION OF HYBRIDOMAS SECRETING MURINE REAGINIC ANTIBODIES OF ANTI-DNP SPECIFICITYESHHAR Z; OFARIM M; WAKS T et al.1980; J. IMMUNOL.; USA; DA. 1980; VOL. 124; NO 2; PP. 775-780; BIBL. 26 REF.Article

INFLUENCIA DE LA DIABETES ALOXANICA SOBRE EL CRECIMIENTO TUMORAL = INFLUENCE DU DIABETE ALLOXANIQUE SUR LA CROISSANCE TUMORALEWAINRACH B; SHANI J; WAKS T et al.1978; REV. CLIN. ESP.; ESP; DA. 1978; VOL. 151; NO 2; PP. 113-117; ABS. ENG/GER/FRE; BIBL. 63 REF.Article

ACTIVATION OF T AND B LYMPHOCYTES IN VITRO. V. CELLULAR LOCUS, METABOLISM AND GENETICS OF INDUCTION, AND PRODUCTION OF THE ALLOGENEIC EFFECT FACTOR.ESHHAR Z; ARMERDING D; WAKS T et al.1977; J. IMMUNOL.; U.S.A.; DA. 1977; VOL. 119; NO 4; PP. 1457-1467; BIBL. 1 P. 1/2Article

CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly asssociated with the T cell receptor-antigen complexLUSTGARTEN, J; WAKS, T; ESHHAR, Z et al.European journal of immunology. 1991, Vol 21, Num 10, pp 2507-2515, issn 0014-2980Article

Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificityGROSS, G; WAKS, T; ESHHAR, Z et al.Proceedings of the National Academy of Sciences of the United States of America. 1989, Vol 86, Num 24, pp 10024-10028, issn 0027-8424, 5 p.Article

Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the γ or ζ subunits of the immunoglobulin and T-cell receptorsESHHAR, Z; WAKS, T; GROSS, G et al.Proceedings of the National Academy of Sciences of the United States of America. 1993, Vol 90, Num 2, pp 720-724, issn 0027-8424Article

Targeting of T lymphocytes to Neu/HER2-expressing cells using chimeric single chain Fv receptorsSTANCOVSKI, I; SCHINDLER, D. G; WAKS, T et al.The Journal of immunology (1950). 1993, Vol 151, Num 11, pp 6577-6582, issn 0022-1767Article